These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 25524636)
1. Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells. Zhou W; Cao A; Wang L; Wu D Cell Biochem Biophys; 2015 May; 72(1):241-9. PubMed ID: 25524636 [TBL] [Abstract][Full Text] [Related]
2. Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-κB-dependent cFLIP expression in HeLa cells. Seo OW; Kim JH; Lee KS; Lee KS; Kim JH; Won MH; Ha KS; Kwon YG; Kim YM Exp Mol Med; 2012 Nov; 44(11):653-64. PubMed ID: 22932446 [TBL] [Abstract][Full Text] [Related]
3. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression. Wang W; Zhao J; Wang H; Sun Y; Peng Z; Zhou G; Fan L; Wang X; Yang S; Wang R; Fang D Exp Cell Res; 2010 Sep; 316(15):2456-64. PubMed ID: 20595005 [TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis. Wei R; Zhu G; Jia N; Yang W Cell Biochem Biophys; 2015 May; 72(1):157-64. PubMed ID: 25539708 [TBL] [Abstract][Full Text] [Related]
5. Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation. Lirdprapamongkol K; Sakurai H; Abdelhamed S; Yokoyama S; Athikomkulchai S; Viriyaroj A; Awale S; Ruchirawat S; Svasti J; Saiki I Int J Oncol; 2013 Jul; 43(1):329-37. PubMed ID: 23636231 [TBL] [Abstract][Full Text] [Related]
6. Bortezomib synergizes TRAIL-induced apoptosis in gastric cancer cells. Liu J; Qu XJ; Xu L; Zang Y; Qu JL; Hou KZ; Liu YP Dig Dis Sci; 2010 Dec; 55(12):3361-8. PubMed ID: 20393880 [TBL] [Abstract][Full Text] [Related]
7. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins. Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508 [TBL] [Abstract][Full Text] [Related]
8. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673 [TBL] [Abstract][Full Text] [Related]
9. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. Zhang T; Wang X; He D; Jin X; Guo P Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080 [TBL] [Abstract][Full Text] [Related]
10. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents. Sánchez-Pérez T; Ortiz-Ferrón G; López-Rivas A Cell Death Differ; 2010 May; 17(5):883-94. PubMed ID: 19942932 [TBL] [Abstract][Full Text] [Related]
11. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432 [TBL] [Abstract][Full Text] [Related]
12. Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling. Du J; Wu J; Fu X; Tse AK; Li T; Su T; Yu ZL Oncotarget; 2016 Aug; 7(32):52218-52229. PubMed ID: 27418138 [TBL] [Abstract][Full Text] [Related]
13. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887 [TBL] [Abstract][Full Text] [Related]
14. The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms. Llobet D; Eritja N; Yeramian A; Pallares J; Sorolla A; Domingo M; Santacana M; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X Eur J Cancer; 2010 Mar; 46(4):836-50. PubMed ID: 20071162 [TBL] [Abstract][Full Text] [Related]
15. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells. Palacios C; Yerbes R; López-Rivas A Cancer Res; 2006 Sep; 66(17):8858-69. PubMed ID: 16951203 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. El-Zawahry A; McKillop J; Voelkel-Johnson C BMC Cancer; 2005 Jan; 5():2. PubMed ID: 15638938 [TBL] [Abstract][Full Text] [Related]
17. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related]
18. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells. Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708 [TBL] [Abstract][Full Text] [Related]
19. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681 [TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]